Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib.

5 years ago

Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib.

Wen-Sou Huang, Bing-Hui Chen, Kang-Shun Zhu, Ming-Yue Cai, Yong-Jian Guo, Jing-Wen Zhou, Jing-Jun Huang, Xiao-Chun Meng

To identify clinical biomarkers that could early predict improved survival in patients with advanced-stage hepatocellular carcinoma (HCC) treated with transarterial chemoembolization combined with sorafenib (TACE-S).

Publisher URL: http://doi.org/10.3748/wjg.v24.i4.484

DOI: 10.3748/wjg.v24.i4.484

You might also like

Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.